Reply to "Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005".

Reply to "Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005".

Paynter, Janine ; Goodyear-Smith, Felicity ; Morgan, Jane ; Saxton, Peter ; Black, Steven ; Petousis-Harris, Helen
Identifier: http://hdl.handle.net/2292/48430
Issue Date: 2019-03-15
Reference: Vaccines 7(1) 15 Mar 2019
Rights: Copyright: The authors
Rights (URI): https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm

Abstract:

Kenyon (2019) is correct to suggest that there is limited evidence of longer term effectiveness.[...].

Show full item record

Files in this item

Thumbnail
Size: 148.4Kb
Format: PDF
Description: Published version
Icon
DOI: 10.3390/vaccines7010032
Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Browse

Statistics